Clinical Trial

Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of the study is to assess the pharmacokinetics (PK) of AZD4144 when administered alone and in combination with itraconazole in healthy participants.
Trial Details
NCT Number NCT07685600
Lead Sponsor AstraZeneca
Conditions Healthy
Enrollment 32 participants
Start Date 2026-07-30
Primary Completion 2026-10-28 (estimated)
Study Completion 2026-10-28 (estimated)
Updated on ClinicalTrials.gov 2026-07-06